These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12180578)
1. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome. Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578 [TBL] [Abstract][Full Text] [Related]
2. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Grigore AM; Brusco L; Kuroda M; Koorn R Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients. Farenc C; Lefrant JY; Audran M; Bressolle F J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage. Tassonyi E; Fathi M; Hughes GJ; Chiodini F; Bertrand D; Muller D; Fuchs-Buder T Acta Anaesthesiol Scand; 2002 Nov; 46(10):1236-41. PubMed ID: 12421196 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation. Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518 [TBL] [Abstract][Full Text] [Related]
7. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Smith CE; van Miert MM; Parker CJ; Hunter JM Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062 [TBL] [Abstract][Full Text] [Related]
9. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Parker CJ; Jones JE; Hunter JM Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome. Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869 [TBL] [Abstract][Full Text] [Related]
11. Plasma laudanosine levels in patients given atracurium during liver transplantation. Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269 [TBL] [Abstract][Full Text] [Related]
12. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055 [TBL] [Abstract][Full Text] [Related]
13. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion. de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604 [TBL] [Abstract][Full Text] [Related]
14. The prolonged use of atracurium in a patient with tetanus. Peat SJ; Potter DR; Hunter JM Anaesthesia; 1988 Nov; 43(11):962-3. PubMed ID: 3213921 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964 [TBL] [Abstract][Full Text] [Related]
17. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery. Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068 [TBL] [Abstract][Full Text] [Related]
18. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg Aguilar A; Andaluz A; Moll X; Cristòfol C; García F Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378 [TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation. Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927 [TBL] [Abstract][Full Text] [Related]
20. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration. Shearer ES; O'Sullivan EP; Hunter JM Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]